US Patent Issued to University of Rochester on July 29 for "Targeted nuclear RNA cleavage and polyadenylation with CRISPR-Cas" (New York Inventor)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,698, issued on July 29, was assigned to University of Rochester (Rochester, N.Y.).

"Targeted nuclear RNA cleavage and polyadenylation with CRISPR-Cas" was invented by Douglas Matthew Anderson (Pittsford, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides proteins, nucleic acids, systems and methods for visualizing or modulating RNA."

The patent was filed on Jan. 14, 2020, under Application No. 17/422,885.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&...